Real-world impact of the COVID-19 pandemic on the assessment of anaesthesiology residents.

Br J Anaesth

The Wilson Centre, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; SickKids Research Institute, Hospital for Sick Children, Toronto, ON, Canada; Division of Gastroenterology, Hepatology and Nutrition, Hospital for Sick Children, University of Toronto, Department of Paediatrics, Toronto, ON, Canada; SickKids Learning Institute, Hospital for Sick Children, Toronto, ON, Canada.

Published: November 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440277PMC
http://dx.doi.org/10.1016/j.bja.2020.08.016DOI Listing

Publication Analysis

Top Keywords

real-world impact
4
impact covid-19
4
covid-19 pandemic
4
pandemic assessment
4
assessment anaesthesiology
4
anaesthesiology residents
4
real-world
1
covid-19
1
pandemic
1
assessment
1

Similar Publications

Background: Myelodysplastic syndromes/neoplasms (MDS) are a diverse group of clonal myeloid disorders. Advances in molecular technology lead to the development of new classification systems. However, large-scale epidemiological studies on MDS in Asian countries are currently scarce.

View Article and Find Full Text PDF

Effectiveness of Tralokinumab in Different Phenotypes of Atopic Dermatitis: A Real-World Study.

Dermatol Ther (Heidelb)

January 2025

Department of Medical-Surgical Sciences and Biotechnologies, Dermatology Unit "Daniele Innocenzi", "Sapienza" University of Rome, Polo Pontino, 04100, Latina, Italy.

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus and a relapsing course, affecting approximately 25% of children and 4-7% of adults. This study evaluated the efficacy, safety, and quality-of-life impact of tralokinumab, a humanized monoclonal antibody targeting interleukin-13 (IL-13), in treating moderate-to-severe AD in a real-world setting, with a focus on different AD phenotypes.

Methods: An observational cohort of 30 adults treated with tralokinumab for ≥ 16 weeks was analyzed.

View Article and Find Full Text PDF

Objectives: To determine whether extending anti-CGRP mAb treatment beyond 3 years influences migraine course, we analyzed migraine frequency during the first month of treatment discontinuation following three 12-month treatment cycles (Ts).

Methods: This multicenter, prospective, real-world study enrolled 212 patients with high-frequency episodic migraine (HFEM) or chronic migraine (CM) who completed three consecutive Ts of subcutaneous anti-CGRP mAbs. Discontinuation periods (D1, D2, D3) were defined as the first month after T1, T2, and T3, respectively.

View Article and Find Full Text PDF

Purpose: Mortality and morbidity of patients with bloodstream infection (BSI) remain high despite advances in diagnostic methods and efforts to speed up reporting. This study investigated the impact of reporting rapid Minimum Inhibitory Concentration (MIC)-results in Gram negative BSIs with the ASTar system (Q-linea, Uppsala, Sweden) on the adaptation of empirically started antimicrobial therapy. We performed a real-world study during which antimicrobial susceptibility testing (AST) results were instantly reported to the treating physician in an established multidisciplinary antimicrobial stewardship setting.

View Article and Find Full Text PDF

Coastal ecosystems are degraded worldwide and oyster reefs are among the most threatened coastal habitats. Oysters are a critical ecosystem engineer and valuable fishery species, thus effective management strategies must balance tradeoffs between protecting reef ecosystems and continued human use. Management practices for oysters commonly incorporate shell replenishment (provisioning hard substrates to increase reef relief) and spatial management (rotational harvest areas or sanctuaries); however, the impact of these practices on reef dynamics and fisheries outcomes are poorly understood, particularly on harvested reefs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!